State Abortion Trigger Laws: Potential Implications for Reproductive Medicine
By ASRM Center for Policy and Leadership,
The American Society for Reproductive Medicine
| 06. 29. 2022
Today, the ASRM Center for Policy and Leadership (CPL) released a new report entitled State Abortion Trigger Laws: Potential Implications for Reproductive Medicine. Current as of the date of publication, the report provides an overview of states’ abortion trigger laws, together with analysis of potential implications for reproductive medicine, including IVF. Read the report here.
As we collectively work to understand the implications of the Supreme Court’s decision in Dobbs v Jackson Women’s Health, please visit our resource pageto access this report, as well as additional resources intended to respond to questions and needs of members and their patients. This report is the first in a series of materials to be released by the CPL. If there are specific resources that would be of use to you or your patients, please let us know: cpl@asrm.org.
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...